Abstract

AbstractLipid vesicles may be safely and efficiently loaded with therapeutic dose levels of the beta emitter yttrium-90 (90Y) by using the ability of the cation ionophore A23187 to transport yttrium across the lipid bilayer where it is chelated on the vesicle interior by diethylenetriamine pentaacetic acid (DTPA). For 100 nm diameter vesicles composed of diplamitoylphosphatidylcholine (DPPC) and cholesterol (Choi), DPPC/Chol (1:1), containing 15 mM DTPA with 40 nmoles of external yttrium, total uptake was > 95% of added yttrium within 5 min at 50° using 0.4 ng of ionophore per nmole of lipid. Background binding in these neutral vesicles accounts for less than 0.1% of the yttrium associated with the vesicles. Important operational parameters were the amount of ionophore (> 0.2 μg of ionophore per μmole of lipid was required) and also the temperature (for DPPC/Chol (1:1) vesicles uptake at 40° was essentially background but was > 95% at 50°). The presence of the polymer polyethylene glycol (PEG) on the memb...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call